Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Global X FinTech ETF
FINX
$170M
| $125K | ﹤0.01% |
6,020
+2,000
| +50% | +$42K |
|
|
OBE
3927
Obsidian Energy
OBE
$716M
| $125K | ﹤0.01% |
19,526
+1,300
| +7% | +$8.46K |
|
3928
Kornit Digital
KRNT
$705M
| $125K | ﹤0.01% |
6,447
-310
| -5% | -$7K |
|
3929
Greenlight Captial
GLRE
$552M
| $125K | ﹤0.01% |
13,273
+6,254
| +89% | +$59K |
|
|
IIVI
3930
DELISTED
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
| $125K | ﹤0.01% |
712
-30,000
| -98% | -$5.42M |
|
3931
Star Holdings Shares of Beneficial Interest
STHO
$113M
| $124K | ﹤0.01% |
+7,131
| New | +$139K |
|
3932
Vuzix
VUZI
$194M
| $124K | ﹤0.01% |
29,946
-17,181
| -36% | -$77.3K |
|
3933
Amplify Energy
AMPY
$161M
| $124K | ﹤0.01% |
18,037
+8,459
| +88% | +$69.4K |
|
3934
Sierra Bancorp
BSRR
$528M
| $124K | ﹤0.01% |
7,174
+3,235
| +82% | +$65K |
|
3935
OptimizeRx
OPRX
$114M
| $124K | ﹤0.01% |
8,442
+265
| +3% | +$4.43K |
|
|
BLFY
3936
DELISTED
Blue Foundry Bancorp
BLFY
| $122K | ﹤0.01% |
12,860
+5,977
| +87% | +$68.6K |
|
3937
Ryan Specialty Holdings
RYAN
$5.72B
| $122K | ﹤0.01% |
3,035
-1,163
| -28% | -$47.8K |
|
|
LIAN
3938
DELISTED
LianBio American Depositary Shares
LIAN
| $122K | ﹤0.01% |
62,269
-66,459
| -52% | -$138K |
|
3939
Home Bancorp
HBCP
$561M
| $122K | ﹤0.01% |
3,684
+1,722
| +88% | +$65K |
|
3940
Douglas Elliman
DOUG
$154M
| $122K | ﹤0.01% |
41,032
+4,488
| +12% | +$17.9K |
|
3941
AB InBev
BUD
$170B
| $121K | ﹤0.01% |
1,818
-6,514
| -78% | -$394K |
|
|
TCFC
3942
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $121K | ﹤0.01% |
3,660
| – | – |
|
|
TSP
3943
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $121K | ﹤0.01% |
82,472
+34,196
| +71% | +$64.7K |
|
3944
KraneShares Global Carbon Strategy ETF
KRBN
$140M
| $121K | ﹤0.01% |
3,053
| – | – |
|
|
BRT
3945
BRT Apartments
BRT
$281M
| $121K | ﹤0.01% |
6,132
+2,902
| +90% | +$59K |
|
3946
Amneal Pharmaceuticals
AMRX
$5.85B
| $121K | ﹤0.01% |
86,993
+24,451
| +39% | +$48.7K |
|
|
DOO
3947
Bombardier Recreational Products
DOO
$4.54B
| $121K | ﹤0.01% |
1,545
-6,842
| -82% | -$564K |
|
3948
Atour Lifestyle Holdings
ATAT
$4.67B
| $121K | ﹤0.01% |
4,600
-239,242
| -98% | -$5.85M |
|
3949
Full House Resorts
FLL
$80.1M
| $120K | ﹤0.01% |
16,658
+7,831
| +89% | +$67.3K |
|
3950
Disc Medicine
IRON
$2.96B
| $119K | ﹤0.01% |
5,619
+5,419
| +2,710% | +$121K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.